[1]张　兰　库洪彬　王　敏　周　燕.动脉瘤性蛛网膜下腔出血病人血清sLOX-1、netrin-1水平变化及其与病人预后的关系[J].中国临床神经外科杂志,2020,(06):377-380.[doi:10.13798/j.issn.1009-153X.2020.06.013]
　ZHANG Lan,KU Hong-bin,WANG Min,et al.Relationship between serum levels of sLOX-1 and netrin-1 and progosis of patients with aneurysmal subarachnoid hemorrhage[J].,2020,(06):377-380.[doi:10.13798/j.issn.1009-153X.2020.06.013]
点击复制

动脉瘤性蛛网膜下腔出血病人血清sLOX-1、netrin-1水平变化及其与病人预后的关系()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2020年06期
页码:
377-380
栏目:
论著
出版日期:
2020-06-15

文章信息/Info

Title:
Relationship between serum levels of sLOX-1 and netrin-1 and progosis of patients with aneurysmal subarachnoid hemorrhage
文章编号:
1009-153X（2020）06-0377-04
作者:
张　兰　库洪彬　王　敏　周　燕
054000 河北，邢台市第三医院神经外三科（张　兰、库洪彬、王　敏、周　燕）
Author(s):
ZHANG Lan;  KU Hong-bin;  WANG Min;  ZHOU Yan.
Department of Neurosurgery, Xingtai Third Hospital, Xingtai 054000, China
关键词:
动脉瘤性蛛网膜下腔出血; 可溶性凝集素样氧化低密度脂蛋白受体-1; 神经轴突导向因子-1; 预后; 影响因素
Keywords:
Aneurysmal subarachnoid hemorrhage;  Soluble lectin-like oxidized low-density lipoprotein receptor-1;  Netrin-1
分类号:
R 743.9; Q 786
DOI:
10.13798/j.issn.1009-153X.2020.06.013
文献标志码:
A
摘要:
目的 探讨动脉瘤性蛛网膜下腔出血（aSAH）病人血清可溶性凝集素样氧化低密度脂蛋白受体-1（sLOX-1）、神经轴突导向因子-1（netrin-1）水平变化及其与病人预后的关系。方法 前瞻性收集2015年1月至2018年7月收治的aSAH病人130例（aSAH组），另选取健康体检者130例为对照组。采用酶联免疫吸附试验法检测血清sLOX-1、netrin-1水平。采用多因素logistic回归分析检验预后影响因素。出院6个月后，采用GOS评分评估预后，4~5分为预后良好，1~3分为预后不良。结果 aSAH组血清sLOX-1水平[（1.762±0.610）ng/ml]明显高于对照组[（0.520±0.040）ng/ml；P<0.05]，而aSAH组血清netrin-1水平[（254.600±87.331）pg/ml]明显低于对照组[（788.534±246.510）pg/ml；P<0.05]。出院后6个月，预后良好78例，预后不良52例。预后良好组血清sLOX-1水平[（1.301±0.560）ng/ml]明显低于预后不良组[（2.236±1.121）ng/ml；P<0.05]，而预后良好组血清netrin-1水平[（318.924±120.660）pg/ml]明显高于预后不良组[（152.358±61.725）pg/ml；P<0.05]。多因素logistic回归分析显示，术前Hung-Hess分级Ⅲ~Ⅳ级、术前改良Fisher分级Ⅲ~Ⅳ级、术前WFNS分级Ⅳ~Ⅴ级、血清sLOX-1增高和血清netrin-1降低是aSAH病人预后不良的独立危险因素（P<0.05）。ROC曲线分析显示，血清sLOX-1、netrin-1联合检测预测aSAH预后不良的曲线下面积为0.923（95%置信区间为0.778~0.923；P<0.001），敏感度和特异度分别为0.842和0.814。结论 血清sLOX-1、netrin-1是aSAH病人不良预后的独立危险因素，可作为评估aSAH预后的生物学标记物
Abstract:
Objective To investigate the relationship between serum levels of soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) and axon guidance factor-1 (netrin-1) and the progosis of patients with aneurysmal subarachnoid hemorrhage (aSAH). Methods The serum levels of sLOX-1 and netrin-1 were measured in 130 patients with aSAH (aSAH group) who were admitted to our hospital from January 2015 to July 2018 and 130 healthy peoples (control group). GOS score was used to evaluate the prognosis 6 months after the discharge. Multivariate logistic regression analysis was used to test the prognostic factors. Results Of 130 patients with aSAH, 78 patients had good prognosis (GOS score of 4~5) and 52 had poor prognosis (GOS score of 1~3). The serum level of sLOX-1 in the aSAH group was significantly higher than that in the control group (P<0.05), and the serum level of netrin-1 was significantly lower than that in the control group (P<0.05). The serum level of sLOX-1 of the patients with good prognosis was significantly lower than that of the patients with poor prognosis (P<0.05), and the serum level of netrin-1 of the patients with good prognosis was significantly higher than the patients with poor prognosis (P<0.05). Multivariate logistic regression analysis showed that the increase in serum level of sLOX-1 and decreased in serun level of netrin-1 were independent risk factors for the poor prognosis of aSAH patients. ROC curve showed that that the area under curve of combined detection of serum sLOX-1 and netrin-1 to predict aSAH’s poor prognosis was 0.923 (95% CI 0.778~0.923; P<0.001), with a sensitivity of 0.842 and a specificity 0.814. Conclusion Serum sLOX-1 and netrin-1 are independent risk factors for the poor prognosis of aSAH patients, which can be used as biological markers to evaluate the prognosis of aSAH patients

参考文献/References:

[1] 廖旭兴，钟伟健，董安石，等. 替罗非班在颅内破裂动脉瘤急性期支架辅助弹簧圈栓塞中的应用[J]. 中国临床神经外科杂志，2019，24（11）：672-674.
[2] 蔡俊杰，孔　滨，苑玉清. 颅内动脉瘤夹闭术中动脉瘤破裂的危险因素分析[J]. 中国临床神经外科杂志，2020，25（3）：149-151.
[3] 李治国，水少锋，韩新巍，等. 颈内动脉多发宽颈动脉瘤的介入治疗分析[J]. 中国临床神经外科杂志，2019，24（8）：453-456.
[4] 幸　标，彭占威，李　俊. 前交通动脉动脉瘤夹闭术后并发中枢性尿崩症的危险因素[J]. 中国临床神经外科杂志，2019，24（10）：586-588.
[5] 汪　峰，姚声涛，王小强，等. 颅内破裂动脉瘤开颅夹闭术后并发肺炎的危险因素[J]. 中国临床神经外科杂志，2019，24（10）：589-591.
[6] 黄永旺，朱　雷，莫万彬，等. 大脑中动脉动脉瘤破裂伴颅内血肿致脑疝的急诊手术治疗[J]. 中国临床神经外科杂志，2020，25（1）：45-46.
[7] 闫　杰，刘艳军，赵　红，等. 冠状动脉慢血流与血清可溶性凝集素样氧化型低密度脂蛋白受体-1及瘦素的关系[J]. 中国循证心血管医学杂志，2018，10（5）：575-577.
[8] 刘淑珍，万大国，马　军，等. Netrin-1对心肌细胞H9c2缺氧复氧损伤中的保护作用研究[J]. 中国循证心血管医学杂志，2019，11（8）：945-949.
[9] Bruikman CS, Vreeken D, Hoogeveen RM, et al. Netrin-1 and the grade of atherosclerosis are inversely correlated in humans [J]. Arterioscler Thromb Vasc Biol, 2020, 40(2): 462-472.
[10] 国家卫生计生委脑卒中防治工程编写委员. 中国动脉瘤性蛛网膜下腔出血诊疗指导规范[J]. 中国脑血管病杂志，2016，13（7）：384-392.
[11] 董晓峰，朱　迪，梁旭光，等. 尼莫地平治疗动脉瘤性蛛网膜下腔出血的效果及对血管内皮因子、炎性因子和HMGB1表达的影响[J]. 临床神经外科杂志，2019，16（3）：262-266.
[12] 田风选. 女性颅内动脉瘤性蛛网膜下腔出血与雌激素缺乏关系研究进展[J]. 中国现代神经疾病杂志，2019，19（9）：634-638.
[13] Lin Q, Ba HJ, Dai JX, et al. Serum soluble lectin-likeoxidized low-density lipoprotein receptor-1 concentrations and prognosis of aneurysmal subarachnoid hemorrhage [J].Clin Chim Acta, 2020, 500: 54-58.
[14] Yang X, Li S, Li B, et al. Netrin-1 overexpression improves neurobehavioral outcomes and reduces infarct size via inhibition of the notch1 pathway following experimental stroke [J]. J Neurosci Res, 2017, 95: 1850-1857.
[15] Guo D, Zhu Z, Zhong C, et al. Increased serum netrin-1 is associated with improved prognosis of ischemic stroke [J]. Stroke, 2019, 50(4): 845-852.
[16] Chen JL, Yuan DH, Yang SJ, et al. Serum netrin-1 serves as a prognostic biomarker of aneurysmal subarachnoid hemorrhage [J]. Clin Chim Acta, 2019, 495: 294-300.

相似文献/References:

[1]郭　芳　张　铭　李中振　梁恩和.动脉瘤性蛛网膜下腔出血后分流依赖性脑积水的危险因素分析[J].中国临床神经外科杂志,2016,(02):73.[doi:10.13798/j.issn.1009-153X.2016.02.004]
　GUO Fang,ZHANG Ming,LI Zhong-zhen,et al.Risk factors related to shunt-dependent hydrocephalus in patients with aneurysmal subarachnoid hemorrhage[J].,2016,(06):73.[doi:10.13798/j.issn.1009-153X.2016.02.004]
[2]邹志鹏　杨　海　夏军勇　张化明　张　华　魏　恒　马江红.行血管内治疗的高龄颅内动脉瘤患者脑血管痉挛的临床分析[J].中国临床神经外科杂志,2015,(07):401.[doi:10.13798/j.issn.1009-153X.2015.07.006]
　ZOU Zhi-peng,YANG Hai,XIA Jun-yong,et al.Clinical analysis of symptomatic cerebral vasospasm after endovascular treatment of ruptured cerebral aneurysms in patients of 70 and over 70 years[J].,2015,(06):401.[doi:10.13798/j.issn.1009-153X.2015.07.006]
[3]郎胜坤　许厚银　董月青　马铁柱　孙　艳　郝芊芊　王慧敏.磁共振灌注成像评估蛛网膜下腔出血后脑血管痉挛的价值[J].中国临床神经外科杂志,2016,(09):517.[doi:10.13798/j.issn.1009-153X.2016.09.002]
　LANG Sheng-kuan,XU Hou-yin,DONG Yue-qing,et al.Evaluation of cerebral vasospasm after aneurysmal subarachnoid hemorrhage by magnetic resonance perfusion weighted imaging[J].,2016,(06):517.[doi:10.13798/j.issn.1009-153X.2016.09.002]
[4]王世龙,赵　冬,许　晖,等.血脂水平与动脉瘤性蛛网膜下腔出血后迟发性脑缺血的相关性[J].中国临床神经外科杂志,2016,(11):685.[doi:10.13798/j.issn.1009-153X.2016.11.011]
　WANG Shi-long,ZHAO Dong,XU Hui,et al.Relationship of serum lipid with delayed cerebral ischemia following the aneurysmal subarachnoid hemorrhage[J].,2016,(06):685.[doi:10.13798/j.issn.1009-153X.2016.11.011]
[5]潘逸珩　雷军荣　段　波　魏德胜　陈　亮　陈志明　秦　军.动脉瘤性蛛网膜下腔出血术后脑梗死的临床特点及其发生的危险因素分析[J].中国临床神经外科杂志,2017,(01):4.[doi:10.13798/j.issn.1009-153X.2017.01.002]
　PAN Yi-heng,LEI Jun-rong,DUAN Bo,et al.Analysis of clinical features of postoperative cerebral infarction and the factors related to it in patients with aneurysmal subarachnoid hemorrhage[J].,2017,(06):4.[doi:10.13798/j.issn.1009-153X.2017.01.002]
[6]谢　飞　陈志远　曾家良　叶勇强.DSA联合血清SICAM-1评估颅内破裂动脉瘤术后脑血管痉挛的效果[J].中国临床神经外科杂志,2017,(09):617.[doi:10.13798/j.issn.1009-153X.2017.09.003]
　XIE Fei CHEN Zhi-yuan ZENG Jia-liang,Ye Yong-qiang.Application of DSA combined with serum SICAM-1 to the evaluation of cerebral vasospasm after SAH due to aneurysmal rupture[J].,2017,(06):617.[doi:10.13798/j.issn.1009-153X.2017.09.003]
[7]阮　东　王　芳　郭丽蕊　彭红梅　陈谦学　刘宝辉.C-反应蛋白与动脉瘤性蛛网膜下腔出血临床预后的关系[J].中国临床神经外科杂志,2017,(09):626.[doi:10.13798/j.issn.1009-153X.2017.09.006]
　RUAN Dong,WANG Fang,GUO Li-rui,et al.Relationship between serum level of C-reactive protein and prognoses in patients with aneurysmal subarachnoid hemorrhage[J].,2017,(06):626.[doi:10.13798/j.issn.1009-153X.2017.09.006]
[8]阿库布千、李祥龙、罗　鑫、周　江、李　昊、刘　亮、 陈礼刚、夏祥国.亚洲人群动脉瘤性蛛网膜下腔出血高压氧辅助治疗疗效的Meta分析[J].中国临床神经外科杂志,2017,(11):757.[doi:10.13798/j.issn.1009-153X.2017.11.008]
　AKU Bu-qian,LI Xiang-long,LUO Xin,et al.Meta-analysis of effects of hyperbaric oxygen therapy on clinical outcomes in Asian patients with aneurysmal subarachnoid hemorrhage[J].,2017,(06):757.[doi:10.13798/j.issn.1009-153X.2017.11.008]
[9]李兵兵　洪景芳　李克磊　张　灏　张尚明　王守森.动脉瘤性蛛网膜下腔出血对脑静脉循环的影响[J].中国临床神经外科杂志,2021,26(01):17.[doi:10.13798/j.issn.1009-153X.2021.01.006]
　LI Bing-bing,HONG Jing-fang,LI Ke-lei,et al.Effects of aneurysmal subarachnoid hemorrhage on cerebral venous circulation[J].,2021,26(06):17.[doi:10.13798/j.issn.1009-153X.2021.01.006]
[10]史祥玉　王守森　望家兴　田　君　彭慧平.SII和PNI与动脉瘤性蛛网膜下腔出血预后的关系[J].中国临床神经外科杂志,2022,27(03):167.[doi:10.13798/j.issn.1009-153X.2022.03.007]
　SHI Xiang-yu,WANG Shou-sen,WANG Jia-xing,et al.Relationship between SNI and PNI with prognosis of patients with aneurysmal subarachnoid hemorrhage[J].,2022,27(06):167.[doi:10.13798/j.issn.1009-153X.2022.03.007]

备注/Memo

备注/Memo:
（2020-03-08收稿，2020-05-13修回）通讯作者：库洪彬，E-mail：greenlandsunny1@163.com
更新日期/Last Update: 2020-06-15